Stocks Health care VTRS
NASDAQ · Health careViatris Inc (VTRS)
Viatris Inc brought in $14.7B of revenue over the twelve months to September 30, 2026, up 4.3% from a year earlier. It posted a net loss of $607.8M. Operating cash flow minus capital spending left $1.9B of free cash flow in fiscal 2025. At September 30, 2026 it held $1.8B in cash against $13.3B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Viatris Inc
- Net worth
- Viatris Inc has a market value (market cap) of $23.9B at the latest share price, and shareholders' equity of $13.7B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $14.3B (-3.0% year on year), with a net loss of $3.5B. Over the 12 months to September 30, 2026: revenue $14.7B, net loss $607.8M.
- Cash flow
- In fiscal 2025 operations brought in $2.3B of cash; after $378.8M of capital spending, free cash flow was $1.9B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Viatris Inc's next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Viatris Inc paid dividends of $0.48 per share in fiscal 2025, a yield of 2.30% at the current price.
What Viatris Inc does
Viatris Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker VTRS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $14.3B | -$3.5B | -$3.00 | $1.9B |
| 2024 | $14.7B | -$634.2M | -$0.53 | $2B |
| 2023 | $15.4B | $54.7M | $0.05 | $2.5B |
| 2022 | $16.3B | $2.1B | $1.71 | $2.6B |
| 2021 | $17.9B | -$1.3B | -$1.05 | $2.6B |
| 2020 | $11.9B | -$669.9M | -$1.11 | $988.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where VTRS ranks in Health care
Dividends
Viatris Inc paid $0.48 per share in fiscal 2025. At the current price that is a yield of 2.30%.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $0.48 | n/a | n/a |
| 2024 | $0.48 | n/a | n/a |
| 2023 | $0.48 | n/a | n/a |
| 2022 | $0.48 | n/a | n/a |
| 2021 | $0.33 | n/a | n/a |
Latest SEC filings
What Viatris Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026Passive stake changed SCHEDULE 13G/A
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue was flat at $3.7B versus the same quarter last year; diluted EPS -$0.28 versus -$0.11.
- November 5, 2026
- October 30, 2026Tender offer SC TO-T
- October 8, 2026Form SC TO-C filing SC TO-C
- October 8, 2026Form SC TO-C filing SC TO-C
- October 8, 2026Material agreement8-KViatris agreed to acquire Pacira BioSciences for $36.50 per share in cash, representing an aggregate equity value of $1.65 billion.
- September 8, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 4.9% to $3.8B versus the same quarter last year; diluted EPS -$0.10 versus $0.00.
Insider trades
What the people running Viatris Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 4 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 15, 2026 | Enrietti AndrewSee Remarks | Exercised options | 25,134 | - |
| August 15, 2026 | Enrietti AndrewSee Remarks | Shares withheld for tax | 10,931 | $177.4K |
| August 15, 2026 | Enrietti AndrewSee Remarks | Exercised options | 999 | - |
| August 15, 2026 | Enrietti AndrewSee Remarks | Shares withheld for tax | 435 | $7.1K |
| June 25, 2026 | Campbell PaulSee Remarks | Soldpre-planned (10b5-1) | 50,076 | $809.8K |
| April 15, 2026 | Le Goff CorinneChief Commercial Officer | Exercised options | 39,344 | - |
| April 15, 2026 | Le Goff CorinneChief Commercial Officer | Shares withheld for tax | 17,450 | $241.9K |
| April 15, 2026 | Le Goff CorinneChief Commercial Officer | Exercised options | 3,644 | - |
Who owns VTRS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Fmr LLC13G, passive with 1 related filers | 11% | September 8, 2026 |
| Vanguard Capital Management13G, passive | 7.36% | April 30, 2026 |
| Davis Selected Advisers13G, passive | 6.5% | August 12, 2026 |
| T. Rowe Price Associates, Inc.13G, passive | 6.3% | May 14, 2025 |
| Davis Selected Advisers, L.P. 85-0360310 ------------------------------------------------------------------------------13G, passive | 5.9% | November 12, 2024 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1,025 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Fmr LLC | 96,662,102 | +80,073,588 |
| BlackRock, Inc. | 86,019,468 | +1,659,664 |
| Vanguard Capital Management LLC | 76,046,939 | +1,330,308 |
| Davis Selected Advisers | 75,232,254 | -2,978,937 |
| Vanguard Portfolio Management LLC | 54,282,080 | +370,843 |
| State Street Corp | 53,069,461 | +835,762 |
| Rubric Capital Management LP | 34,168,743 | +668,743 |
| Geode Capital Management, LLC | 32,807,906 | +961,799 |
| Dimensional Fund Advisors LP | 29,970,094 | -8,340,599 |
| Invesco Ltd. | 20,771,275 | -1,197,382 |
| Deerfield Management Company, L.P. | 20,206,170 | 0 |
| Ameriprise Financial Inc | 18,815,747 | -1,199,219 |
| Morgan Stanley | 15,128,899 | -961,040 |
| Bank of New York Mellon Corp | 14,288,053 | +159,136 |
| Charles Schwab Investment Management Inc | 13,567,342 | -106,964 |
| Goldman Sachs Group Inc | 13,564,872 | -152,750 |
| Northern Trust Corp | 10,038,691 | -412,673 |
| Assenagon Asset Management S.A. | 9,978,012 | +9,194,878 |
| Glenview Capital Management, LLC | 9,877,409 | +790,165 |
| Arrowstreet Capital, Limited Partnership | 8,371,218 | -173,978 |
Insiders
17 insiders reported holding 3,110,231 shares in total, about $64.8M at the last price.
| Holder | Shares |
|---|---|
| Smith Scott AndrewChief Executive Officer, Director | 1,329,326 |
| Campbell PaulSee Remarks | 316,212 |
| Enrietti AndrewSee Remarks | 234,444 |
| Parrish Mark WDirector | 165,230 |
| Kilts James MDirector | 161,257 |
| Higgins Melina EDirector | 146,048 |
| Mark Richard ADirector | 116,145 |
| Cornwell W DonDirector | 112,044 |
| Le Goff CorinneChief Commercial Officer | 107,135 |
| Lyons Dillon JoEllenDirector | 102,526 |
Questions about VTRS
What does Viatris Inc do?
Viatris Inc is a company in the Health care sector, listed on NASDAQ as VTRS. Its shares trade on NASDAQ under the ticker VTRS.
What is Viatris Inc's net worth?
Viatris Inc has a market value (market cap) of $23.9B at the latest share price, and shareholders' equity of $13.7B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Viatris Inc profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $607.8M on revenue of $14.7B.
How much revenue does Viatris Inc make?
Over the twelve months to September 30, 2026 Viatris Inc reported revenue of $14.7B. That is 4.3% more than a year earlier.
When did Viatris Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the passive stake changed from November 6, 2026.
When is Viatris Inc's next earnings report?
Viatris Inc's next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does Viatris Inc pay a dividend?
Yes. Viatris Inc paid dividends of $0.48 per share in fiscal 2025, a yield of 2.30% at the current price.
Similar companies
Compare VTRS with
Follow VTRS
Get an email when Viatris Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Viatris Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.